Biologics are a powerful therapeutic option with applications across many indications. However, traditional fed-batch manufacturing makes scaling from clinical to commercial supply difficult. J.POD® technology, a modular continuous manufacturing approach, enables highly intensified cGMP production at scalable quantities, reducing both scale-up risks and costs. Evotec Biologics’ second J.POD® facility is a key step toward making biologics more globally accessible.